Cerebral organoids as an in vitro model to study autism spectrum disorders.
Alexa RabelingMubeen GoolamPublished in: Gene therapy (2022)
Autism spectrum disorders (ASDs) are a set of disorders characterised by social and communication deficits caused by numerous genetic lesions affecting brain development. Progress in ASD research has been hampered by the lack of appropriate models, as both 2D cell culture as well as animal models cannot fully recapitulate the developing human brain or the pathogenesis of ASD. Recently, cerebral organoids have been developed to provide a more accurate, 3D in vitro model of human brain development. Cerebral organoids have been shown to recapitulate the foetal brain gene expression profile, transcriptome, epigenome, as well as disease dynamics of both idiopathic and syndromic ASDs. They are thus an excellent tool to investigate development of foetal stage ASDs, as well as interventions that can reverse or rescue the altered phenotypes observed. In this review, we discuss the development of cerebral organoids, their recent applications in the study of both syndromic and idiopathic ASDs, their use as an ASD drug development platform, as well as limitations of their use in ASD research.
Keyphrases
- autism spectrum disorder
- intellectual disability
- subarachnoid hemorrhage
- attention deficit hyperactivity disorder
- cerebral ischemia
- genome wide
- traumatic brain injury
- dna methylation
- physical activity
- mental health
- white matter
- brain injury
- resting state
- rna seq
- induced pluripotent stem cells
- single cell
- blood brain barrier